Drugs for Gastrointestinal Diseases — MCQs

Drugs for Gastrointestinal Diseases Indian Medical PG Practice Questions and MCQs

Question 151: Which selective 5-HT4 agonist is useful in gastroesophageal reflux disease and lacks arrhythmogenic properties?

A. Buspirone
B. Sumatriptan
C. Cisapride
D. Tegaserod (Correct Answer)

Explanation: **Explanation** **Correct Answer: D. Tegaserod** **Mechanism and Rationale:** Tegaserod is a **selective 5-HT4 receptor partial agonist**. Activation of 5-HT4 receptors on the presynaptic terminals of enteric neurons triggers the release of acetylcholine, which enhances the propulsive movement of the GI tract (prokinetic effect) and increases lower esophageal sphincter (LES) tone. Unlike older prokinetics, Tegaserod is highly selective for the 5-HT4 receptor and **does not block hERG potassium channels**. This lack of hERG inhibition means it does not cause QT interval prolongation or life-threatening ventricular arrhythmias (Torsades de Pointes), making it safer from a cardiac standpoint than drugs like Cisapride. **Analysis of Incorrect Options:** * **A. Buspirone:** An anxiolytic that acts as a **5-HT1A partial agonist**. It has no significant prokinetic activity. * **B. Sumatriptan:** A **5-HT1B/1D agonist** used primarily in the acute treatment of migraine; it causes vasoconstriction rather than GI motility. * **C. Cisapride:** While it is a 5-HT4 agonist used for GERD, it is notorious for causing **cardiac arrhythmias** (Torsades de Pointes) due to its off-target blockade of K+ channels. It has been withdrawn or strictly restricted in many markets. **NEET-PG High-Yield Pearls:** * **Prucalopride:** A newer, highly selective 5-HT4 agonist currently preferred for chronic constipation with an excellent cardiac safety profile. * **Cisapride/Mosapride/Itopride:** Often compared in exams. Mosapride and Itopride are considered safer alternatives to Cisapride as they lack significant QT-prolonging effects. * **Tegaserod Status:** Though safer than Cisapride regarding arrhythmias, it was briefly withdrawn due to an association with ischemic cardiovascular events (MI/Stroke) but has been reintroduced for restricted use in specific IBS-C cases.

Question 152: A patient is on long-term ketoconazole therapy and has developed gastroesophageal reflux disease (GERD). Which of the following drugs should not be used for the treatment of GERD in this patient?

A. Itopride
B. Cisapride (Correct Answer)
C. Metoclopramide
D. Domperidone

Explanation: **Explanation:** The correct answer is **Cisapride** because of a dangerous drug-drug interaction involving the cytochrome P450 (CYP) enzyme system. **1. Why Cisapride is the correct answer:** Cisapride is a prokinetic agent that is metabolized primarily by the **CYP3A4** enzyme [2]. Ketoconazole is a potent **CYP3A4 inhibitor** [2]. When taken together, ketoconazole inhibits the metabolism of Cisapride, leading to significantly elevated plasma levels of the drug. High levels of Cisapride are associated with a serious cardiac side effect: **prolongation of the QT interval**, which can progress to a life-threatening ventricular arrhythmia known as **Torsades de Pointes** [1]. Due to this risk, Cisapride has been largely withdrawn or restricted in many markets [1]. **2. Why the other options are incorrect:** * **Itopride:** It is a prokinetic with a dual mechanism (D2 antagonism and AChE inhibition). Crucially, it is metabolized by **flavin-containing monooxygenase (FMO3)**, not CYP3A4, making it safe to use with ketoconazole. * **Metoclopramide:** This is a D2 receptor antagonist. While it has central side effects (like EPS), its metabolism does not involve the specific CYP3A4 pathway that leads to the cardiotoxicity seen with Cisapride. * **Domperidone:** Although it can cause QT prolongation at very high doses, it is generally considered safer than Cisapride in this context. However, in clinical practice, caution is still advised when combining it with potent CYP3A4 inhibitors. **Clinical Pearls for NEET-PG:** * **Macrolides (Erythromycin) + Cisapride:** This is another classic "contraindicated" combination frequently tested, as macrolides also inhibit CYP3A4 [2]. * **Prucalopride:** A newer 5-HT4 agonist used for chronic constipation; it does not carry the same cardiotoxicity risk as Cisapride. * **Rule of Thumb:** Always look for "QT prolongation" or "Torsades de Pointes" when a question combines a CYP3A4 inhibitor (Ketoconazole, Clarithromycin, Ritonavir) with Cisapride, Terfenadine, or Astemizole [1].

Question 153: What is the drug of choice for the prophylaxis of motion sickness?

A. Scopolamine (Correct Answer)
B. Ondansetron
C. Metoclopramide
D. Domperidone

Explanation: Motion sickness is triggered by vestibular overstimulation, which sends signals via the vestibulocochlear nerve to the vestibular nuclei. These nuclei are rich in M1 (Muscarinic) and H1 (Histaminic) receptors. Scopolamine is a potent centrally acting anticholinergic that blocks M1 receptors in the vestibular apparatus and the vomiting center. It is the **drug of choice for prophylaxis** because it is most effective when administered before the onset of symptoms (usually as a transdermal patch applied 4 hours before travel) [1, 3]. **2. Why the other options are incorrect:** * **Ondansetron:** This is a 5-HT3 receptor antagonist. While it is the drug of choice for chemotherapy-induced nausea and vomiting (CINV) and post-operative vomiting, it is **ineffective** in motion sickness because 5-HT3 receptors are not involved in the vestibular pathway [2]. * **Metoclopramide & Domperidone:** These are D2 receptor antagonists (prokinetics). They act primarily on the Chemoreceptor Trigger Zone (CTZ) and the upper GI tract. They have no significant effect on the vestibular system and are therefore not used for motion sickness [2]. **3. High-Yield Clinical Pearls for NEET-PG:** * **Route of Choice:** The **transdermal patch** (applied behind the pinna) is preferred to minimize systemic side effects like sedation and dry mouth. * **Timing:** Antiemetics for motion sickness must be taken **prophylactically**; they are much less effective once vomiting has started [3]. * **Alternative:** If an antihistamine is used, **Promethazine** or **Cyclizine** are common choices [2]. * **Morning Sickness (Pregnancy):** The drug of choice is a combination of **Doxylamine + Pyridoxine (Vit B6)**. * **Post-Operative Nausea/Vomiting (PONV):** Ondansetron is the drug of choice.

Question 154: Stimulant purgatives are contraindicated in which of the following conditions?

A. Bedridden patients
B. Before abdominal radiography
C. Subacute intestinal obstruction (Correct Answer)
D. All of these

Explanation: **Explanation:** **1. Why Subacute Intestinal Obstruction is the Correct Answer:** Stimulant purgatives (e.g., Bisacodyl, Senna, Castor oil) work by irritating the intestinal mucosa or stimulating the myenteric plexus, leading to increased propulsive peristaltic activity. In the presence of a mechanical obstruction (like subacute intestinal obstruction), forcing peristalsis against a blocked lumen can lead to severe abdominal cramps, vomiting, and—most critically—**intestinal perforation or ischemia**. Therefore, any form of bowel obstruction is an absolute contraindication for stimulant laxatives. **2. Analysis of Incorrect Options:** * **A. Bedridden patients:** These patients often suffer from constipation due to lack of mobility. While bulk-forming laxatives or stool softeners are preferred first-line, stimulant purgatives are **not contraindicated** and are frequently used for short-term relief. * **B. Before abdominal radiography:** Stimulant purgatives (like Bisacodyl) are actually **indicated** before abdominal X-rays or colonoscopies to clear the bowel of fecal matter, ensuring better visualization of the anatomy. * **D. All of these:** Incorrect, as the contraindication is specific to obstructive pathologies. **3. NEET-PG High-Yield Pearls:** * **Classification:** Stimulant purgatives are also known as "Irritant purgatives." * **Castor Oil:** Contains ricinoleic acid; it is unique because it acts primarily in the small intestine. It is now largely obsolete for constipation. * **Anthraquinones (Senna/Cascara):** Can cause **Melanosis Coli** (brownish-black pigmentation of the colonic mucosa) upon chronic use. * **Contraindications:** Apart from obstruction, they are contraindicated in undiagnosed abdominal pain, acute appendicitis, and late pregnancy (may induce pelvic congestion/reflex uterine contractions).

Question 155: Antacid combinations of magnesium and aluminum salts are superior to single component preparations because?

A. They have rapid as well as sustained acid neutralizing action
B. They are less likely to affect gastric emptying
C. They are less likely to alter bowel movement
D. All of the above (Correct Answer)

Explanation: ### Explanation The combination of Magnesium (Mg) and Aluminum (Al) salts is the gold standard in antacid therapy because it optimizes efficacy while neutralizing the side effects of each individual component. **1. Why "All of the Above" is Correct:** * **Rapid and Sustained Action (Option A):** Magnesium hydroxide is highly soluble and reacts quickly with HCl, providing **rapid relief**. Aluminum hydroxide is less soluble and reacts slowly, providing a **sustained effect**. Together, they cover the immediate and maintenance phases of acid neutralization. * **Gastric Emptying (Option B):** Magnesium salts tend to increase the rate of gastric emptying, whereas Aluminum salts delay it. In combination, these opposing effects cancel out, maintaining a relatively **normal gastric emptying rate**. * **Bowel Movements (Option C):** This is the most clinically significant reason. Magnesium salts are osmotic laxatives (causing **diarrhea**), while Aluminum salts are astringent and cause **constipation**. Their combination results in a neutral effect on bowel habits. **2. Clinical Pearls for NEET-PG:** * **Systemic vs. Non-systemic:** Mg and Al salts are **non-systemic antacids**; they are not absorbed into the blood and do not cause systemic alkalosis (unlike Sodium Bicarbonate). * **Drug Interactions:** Antacids can decrease the absorption of drugs like **Tetracyclines, Iron, and Fluoroquinolones** by forming insoluble chelates or altering gastric pH. * **Renal Caution:** In patients with renal failure, Aluminum can accumulate (leading to encephalopathy or osteomalacia) and Magnesium can cause hypermagnesemia. * **Milk-Alkali Syndrome:** Historically associated with Calcium Carbonate intake, characterized by hypercalcemia and metabolic alkalosis.

Question 156: Which of the following is an effective antispasmodic agent for the treatment of intestinal colic?

A. Hyoscine
B. Dicyclomine
C. Propantheline
D. All of the above (Correct Answer)

Explanation: **Explanation:** The correct answer is **D. All of the above**. Intestinal colic is characterized by spasmodic contractions of the smooth muscles in the gastrointestinal tract. To relieve this pain, **antispasmodic agents** are used. These drugs primarily belong to the **Anticholinergic (Antimuscarinic)** class. They work by blocking $M_3$ receptors on the visceral smooth muscles, leading to decreased tone and motility (spasmolytic effect). * **Hyoscine (Scopolamine):** A belladonna alkaloid that acts as a potent antispasmodic. It is available as Hyoscine butylbromide, which is poorly absorbed across the blood-brain barrier, making it effective for peripheral colicky pain with fewer central side effects. * **Dicyclomine:** A tertiary amine that possesses direct smooth muscle relaxant activity in addition to its anticholinergic properties. It is frequently used for irritable bowel syndrome (IBS) and intestinal colic. * **Propantheline:** A synthetic quaternary ammonium compound with high antimuscarinic potency. Due to its ionized nature, it has poor CNS penetration and is used specifically for GI spasms and peptic ulcer disease (to reduce gastric secretion). **High-Yield NEET-PG Pearls:** 1. **Drug of Choice:** For acute biliary or renal colic, injectable Hyoscine or Dicyclomine are commonly used. 2. **Contraindications:** Anticholinergics should be avoided in patients with **Glaucoma** (increases intraocular pressure) and **Prostatic Hyperplasia** (causes urinary retention). 3. **Drotaverine:** Another high-yield antispasmodic often tested; it is a **PDE-4 inhibitor**, not an anticholinergic, making it safe in patients where atropine-like drugs are contraindicated.

Question 157: Which antibiotic is known to cause pseudomembranous colitis?

A. Clindamycin
B. Gentamicin
C. Erythromycin (Correct Answer)
D. Vancomycin

Explanation: **Explanation:** **Pseudomembranous colitis (PMC)** is caused by the overgrowth of *Clostridioides difficile* following the suppression of normal gut flora by broad-spectrum antibiotics. **Why Erythromycin is the Correct Answer:** While many antibiotics can trigger PMC, **Erythromycin** (a Macrolide) is a well-documented cause. It disrupts the intestinal microbiota, allowing *C. difficile* to proliferate and release toxins (Toxin A and B), leading to mucosal inflammation and "pseudomembrane" formation. In the context of this specific question, it is the most appropriate choice among the options provided. **Analysis of Other Options:** * **Clindamycin (Option A):** Historically, Clindamycin was the antibiotic most strongly associated with PMC. However, in modern clinical practice, Cephalosporins and Fluoroquinolones are more frequent causes due to higher prescription volumes. (Note: If this were a "most common cause" question, Clindamycin would be a primary contender). * **Gentamicin (Option B):** As an Aminoglycoside, Gentamicin is primarily active against aerobic gram-negative bacteria and is poorly absorbed from the gut. It is rarely associated with PMC. * **Vancomycin (Option C):** Oral Vancomycin is actually the **treatment of choice** for PMC. It is not a cause; it is used to eradicate *C. difficile*. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice:** Oral Vancomycin or Fidaxomicin are first-line treatments for PMC. * **Alternative:** Metronidazole was previously first-line but is now reserved for mild cases or when other drugs are unavailable. * **Diagnosis:** Confirmed by detecting *C. difficile* toxins in stool or via colonoscopy (showing yellow-white plaques). * **Motilin Agonist:** Erythromycin also acts as a motilin receptor agonist, often causing diarrhea as a side effect independent of PMC.

Question 158: Which of the following drugs does NOT cause constipation?

A. Verapamil
B. Quinidine (Correct Answer)
C. MAO inhibitor
D. Tricyclic antidepressants

Explanation: The correct answer is **Quinidine**. **1. Why Quinidine is the correct answer:** Quinidine is a Class IA antiarrhythmic agent. Unlike many drugs that slow down gut motility, Quinidine is notorious for causing **diarrhea** (occurring in about 30-50% of patients) rather than constipation. This is often referred to as "Quinidine-induced syncope" if the resulting electrolyte imbalance leads to Torsades de Pointes. It does not possess significant anticholinergic or calcium-channel blocking effects on the GI smooth muscle that would lead to constipation. **2. Why the other options are incorrect:** * **Verapamil (Option A):** This is a non-dihydropyridine Calcium Channel Blocker (CCB). It is the CCB most strongly associated with **constipation** because it blocks L-type calcium channels in the colonic smooth muscle, significantly reducing peristalsis [1]. * **MAO Inhibitors (Option C):** Monoamine Oxidase Inhibitors (e.g., Phenelzine) frequently cause constipation as a common side effect due to their complex effects on the autonomic nervous system and peripheral neurotransmitter levels. * **Tricyclic Antidepressants (Option D):** TCAs (e.g., Amitriptyline, Imipramine) have potent **antimuscarinic (anticholinergic) properties**. By blocking M3 receptors on the intestinal smooth muscle, they decrease GI motility, leading to prominent constipation [2]. **3. High-Yield NEET-PG Pearls:** * **Verapamil** is the "classic" drug-induced constipation example in exams [1]. * **Anticholinergic Toxidrome:** Remember the mnemonic "Dry as a bone, Red as a beet, Mad as a hatter" – constipation is a key component due to decreased secretions and motility [2]. * **Other drugs causing constipation:** Opioids (via μ-receptors), Aluminum hydroxide antacids, and Iron supplements. * **Quinidine Side Effects:** Cinchonism (tinnitus, headache, dizziness), thrombocytopenia, and QT prolongation.

Question 159: Which of the following is a prokinetic drug with no dopamine antagonism?

A. Chlorpromazine
B. Metaclopramide
C. Domperidone
D. Mosapride (Correct Answer)

Explanation: **Explanation:** The correct answer is **Mosapride**. To understand why, we must look at the mechanism of action of prokinetic agents, which primarily work by increasing acetylcholine release in the myenteric plexus. **1. Why Mosapride is correct:** Mosapride is a **selective 5-HT₄ receptor agonist**. Activation of 5-HT₄ receptors on the enteric neurons facilitates the release of acetylcholine, enhancing gastrointestinal motility. Crucially, Mosapride lacks any dopamine (D₂) receptor antagonistic activity. This makes it a "pure" prokinetic with a superior safety profile regarding neurological side effects. **2. Why the other options are incorrect:** * **Chlorpromazine (Option A):** This is a typical antipsychotic. While it is a potent D₂ antagonist, it is not used as a prokinetic; in fact, its anticholinergic properties often cause constipation. * **Metoclopramide (Option B):** This is a D₂ antagonist and a 5-HT₄ agonist. Because it crosses the blood-brain barrier, its D₂ antagonism causes significant extrapyramidal side effects (EPS) like dystonia and parkinsonism. * **Domperidone (Option C):** This is a peripheral D₂ antagonist. While it has fewer CNS effects than metoclopramide, its prokinetic action is still mediated via dopamine receptor blockade. **3. High-Yield Clinical Pearls for NEET-PG:** * **Prucalopride:** A highly selective 5-HT₄ agonist used specifically for chronic idiopathic constipation. * **Side Effects:** Unlike Metoclopramide and Domperidone, Mosapride does **not** cause hyperprolactinemia or extrapyramidal symptoms because it does not block D₂ receptors. * **Cardiac Safety:** Unlike its predecessor *Cisapride* (which was withdrawn due to QT prolongation and Torsades de Pointes), Mosapride does not block cardiac K⁺ channels and is considered safer. * **Drug of choice:** Metoclopramide remains a drug of choice for diabetic gastroparesis, but its use is limited to <12 weeks due to the risk of tardive dyskinesia.

Question 160: Which of the following 5-HT3 blockers has the highest receptor affinity?

A. Ondansetron
B. Granisetron
C. Dolasetron
D. Palonosetron (Correct Answer)

Explanation: ### Explanation **Correct Answer: D. Palonosetron** **1. Why Palonosetron is the Correct Answer:** Palonosetron is a **second-generation 5-HT3 receptor antagonist**. It is distinguished from first-generation agents (Ondansetron, Granisetron, Dolasetron) by its significantly **higher receptor affinity** (approximately 30 to 100 times higher) and a much longer elimination **half-life (~40 hours)**. Unlike other blockers, Palonosetron exhibits **allosteric binding** and triggers **receptor internalization**, leading to prolonged inhibition of the 5-HT3 receptor. Because of these properties, it is the only 5-HT3 antagonist FDA-approved for the prevention of **delayed chemotherapy-induced nausea and vomiting (CINV)**, whereas others are primarily effective for the acute phase. **2. Why Other Options are Incorrect:** * **A. Ondansetron:** The prototype first-generation 5-HT3 blocker. It has a short half-life (~3–4 hours) and lower binding affinity compared to Palonosetron. * **B. Granisetron:** A first-generation agent that is more potent than Ondansetron but still possesses significantly lower affinity and a shorter duration of action than Palonosetron. * **C. Dolasetron:** Another first-generation agent. Its active metabolite, hydrodolasetron, is responsible for its action. It is rarely used now due to the risk of **QTc interval prolongation**. **3. High-Yield Clinical Pearls for NEET-PG:** * **Mechanism of Action:** Blocks 5-HT3 receptors on vagal afferents in the GI tract and the Chemoreceptor Trigger Zone (CTZ). * **Drug of Choice:** 5-HT3 blockers are the DOC for **CINV** and **Post-operative nausea and vomiting (PONV)**. * **Side Effects:** Headache (most common), constipation, and QTc prolongation (least risk with Palonosetron). * **Ineffectiveness:** These drugs are **not effective** in motion sickness (which is mediated by H1 and M1 receptors).

Practice by Chapter

Acid-Peptic Disease Therapeutics

Practice Questions

Proton Pump Inhibitors

Practice Questions

H2 Receptor Antagonists

Practice Questions

Antacids and Mucosal Protectants

Practice Questions

Antiemetics

Practice Questions

Prokinetic Agents

Practice Questions

Laxatives and Purging Agents

Practice Questions

Antidiarrheal Drugs

Practice Questions

Drugs for Inflammatory Bowel Disease

Practice Questions

Pancreatic Enzyme Supplements

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free